抗偏头痛新药洛美利嗪

被引:7
作者
郑莉
刘国卿
机构
[1] 中国药科大学药理教研室
[2] 中国药科大学药理教研室 南京
[3] 南京
关键词
洛美利嗪; 抗偏头痛药; 钙通道拮抗剂;
D O I
暂无
中图分类号
R971 [神经系统药物];
学科分类号
1007 ;
摘要
洛美利嗪 ,一种新型二苯哌嗪类衍生物 ,目前临床上主要治疗偏头痛和丛集性头痛。洛美利嗪与氟桂利嗪等钙通道拮抗剂不同 ,具有钙通道和钠通道双重阻断作用 ,洛美利嗪在nmol·L-1至 μmol·L-1水平 ,在多部位具有生物活性 ,包括血管和神经元钙通道、钠通道、α1肾上腺素受体和 5 HT2 受体 ,以及自由基清除作用。本文综述了洛美利嗪的药理作用、药动学与临床疗效等。
引用
收藏
页码:178 / 181
页数:4
相关论文
共 20 条
[11]  
Neurochemical investigation on the effects of a new diphenylpiperazine calcium antagonist,KB-2796, on the central dopaminergic system of rats. Ikegami A,Ozaki A,Hara H,et al. Japanese Journal of Pharmacology . 1992
[12]  
Effects of Ca2+ channel blockers on cortical hypoperfusion and expression of c-Fos-like immunoreactivity after cortical spreading depression in rats. Shimazawa M,Hara H,Watano T,et al. British Journal of Pharmacology . 1995
[13]  
Cortical spreading depression in migraine. Lauritzen M. Cephalalgia . 2001
[14]  
Selective effects of lomerizine, a novel diphenylpiperazine Ca2+ channel blocker, on cerebral blood flow in rats and dogs. Hara H,Shimazawa M,Sasaoka M,et al. Clinical and Experimental Pharmacology and Physiology . 1999
[15]  
Inhibitory effect of lomerizine, a diphenylpiperazine Ca2+-channel blocker, on Ba2+ current through voltage-gated Ca2+ channels in PC12 cells. Watano T,Hara H,Sukamoto T. Japanese Journal of Pharmacology . 1997
[16]  
ClinicalEvaluationofLom erizineonMigraine.Double blindStudyinComparisonwithDimetotiazine. FumioG,KunioT,NaoyukiK ,etal. RinshoHyoka . 1995
[17]  
Synthesis and structure-activity relationships of benzylpiperazine derivatives as potential cerebral vasodilators. Ohtaka H,Kanazawa T,Ito K. Journal of Pharmacobio Dynamics . 1987
[18]  
Biochemical mechanisms in the physiopathology of migraine. Manivet P,Soliman HR,Callebert J,et al. Pathologie Biologie . 2000
[19]  
Effects of lomerizine, a new Ca2+ entry blocker, on the contractile response of isolated canine cerebral and peripheral arteries. Harada K,Nakamura A,Dobashi R,et al. Japanese Pharmacology and Therapeutics . 1997
[20]  
Selective effect of KB2796, a new calcium entry blocker, on cerebral circulation: a comparative study of the effects of calcium entry blockers on cerebral and peripheral arterial blood flows. Kanazawa T,Morita T,Harada K,et al. Journal of Cardiovascular Pharmacology . 1990